Faculty
Nirmala Gonsalves, MD, AGAF, FACG
Professor of Medicine
Co-director, Northwestern Eosinophilic Disorders Program
Division of Gastroenterology & Hepatology, Northwestern University
The Feinberg School of Medicine
Chicago, IL
PROGRAM OVERVIEW
This podcast will discuss the importance of understanding the etiopathogenesis of eosinophilic esophagitis (EoE), the role of specific cytokines in this immune-mediated, antigen-driven disease, and the commonly presenting symptomatology as an aid to prompt diagnosis of EoE.
TARGET AUDIENCE
This activity is designed to meet the educational needs of gastroenterologists, allergist/immunologists, ENT specialists, primary care physicians, nurse practitioners, and other members of the multidisciplinary team to ensure optimal patient outcomes in the management of EoE.
LEARNING OBJECTIVE
Upon the completion of this program, attendees should be able to:
- Detail the etiopathogenesis of eosinophilic esophagitis as foundational knowledge for prompt diagnosis
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
Faculty Member | Disclosures |
Nirmala Gonsalves, MD, AGAF, FACG | Dr. Gonsalves discloses that she has received royalties from UpToDate and consulting fees from AstraZeneca, Bristol Myers Squibb, Sanofi and Regeneron Pharmaceuticals, Inc., AbbVie, and Knopp Biosciences. |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Anita Misra-Press, PhD, Medical Director for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Lisa Crenshaw, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Morgan Kravarik, Associate Program Manager for Med Learning Group, has nothing to disclose.
- Daniel Dasilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
- Jacquelyn Sandfort, Program Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg. Physical, Dietary, etc.). Please contact Med Learning Group prior to participating at [email protected]
Please listen to the podcast below:
RELEASED DATE: September 28, 2023
EXPIRATION DATE: September 28, 2024
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
Faculty
Nirmala Gonsalves, MD, AGAF, FACG
Professor of Medicine
Co-director, Northwestern Eosinophilic Disorders Program
Division of Gastroenterology & Hepatology, Northwestern University
The Feinberg School of Medicine
Chicago, IL
Kim Pfotenhauer, DO, FACOFP
Assistant Professor of Family Medicine
Assistant Dean for Clerkship Education
Michigan State University, College of Osteopathic Medicine
East Lansing, MI
PROGRAM OVERVIEW
This podcast will discuss the importance of identifying key symptoms and clinical presentation of eosinophilic esophagitis (EoE), from a family medicine perspective.
TARGET AUDIENCE
This activity is designed to meet the educational needs of gastroenterologists, allergist/immunologists, ENT specialists, primary care physicians, nurse practitioners, and other members of the multidisciplinary team to ensure optimal patient outcomes in the management of EoE.
LEARNING OBJECTIVE
Upon the completion of this program, attendees should be able to:
- Describe the key symptomatology and clinical presentation of EoE
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
Faculty Member | Disclosures |
Nirmala Gonsalves, MD, AGAF, FACG | Dr. Gonsalves discloses that she has received royalties from UpToDate and consulting fees from AstraZeneca, BMS, Sanofi-Regeneron, AbbVie, and Knopp Biosciences. |
Kim Photenhauer, DO, FACOFP | Dr. Pfotenhauer discloses that she receives consulting fees from Abbott Laboratories. |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Anita Misra-Press, PhD, Medical Director for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Lisa Crenshaw, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Morgan Kravarik, Associate Program Manager for Med Learning Group, has nothing to disclose.
- Daniel Dasilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
- Jacquelyn Sandfort, Program Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg. Physical, Dietary, etc.). Please contact Med Learning Group prior to participating at [email protected]
Please listen to the podcast below:
RELEASED DATE: September 28, 2023
EXPIRATION DATE: September 28, 2024
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
Faculty
Nirmala Gonsalves, MD, AGAF, FACG
Professor of Medicine
Co-director, Northwestern Eosinophilic Disorders Program
Division of Gastroenterology & Hepatology, Northwestern University
The Feinberg School of Medicine
Chicago, IL
Alexandra A. Horwitz, MD, FAAAAI
Associate Professor of Pediatrics and Medicine
Division of Allergy-Immunology
Penn State Health Children’s Hospital
Hershey, PA
PROGRAM OVERVIEW
This podcast will discuss the evolving treatment landscape for eosinophilic esophagitis (EoE), including latest clinical evidence for biologic therapies from an allergist’s perspective.
TARGET AUDIENCE
This activity is designed to meet the educational needs of gastroenterologists, allergist/immunologists, ENT specialists, primary care physicians, nurse practitioners, and other members of the multidisciplinary team to ensure optimal patient outcomes in the management of EoE.
LEARNING OBJECTIVE
Upon the completion of this program, attendees should be able to:
- Assess the latest clinical evidence for biologic therapies in the treatment of EoE
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
Faculty Member | Disclosures |
Nirmala Gonsalves, MD, AGAF, FACG | Dr. Gonsalves discloses that she has received royalties from UpToDate and consulting fees from AstraZeneca, Bristol Myers Squibb, Sanofi and Regeneron Pharmaceuticals, Inc., AbbVie, and Knopp Biosciences. |
Alexandra A. Horwitz, MD FAAAAI | Dr. Horwitz has nothing to disclose. |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed. The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Anita Misra-Press, PhD, Medical Director for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Lisa Crenshaw, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Morgan Kravarik, Associate Program Manager for Med Learning Group, has nothing to disclose.
- Daniel Dasilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
- Jacquelyn Sandfort, Program Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg. Physical, Dietary, etc.). Please contact Med Learning Group prior to participating at [email protected]
Please listen to the podcast below:
RELEASED DATE: October 20, 2023
EXPIRATION DATE: October 20, 2024
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.